Precipio, Inc. (PRPO)
NASDAQ: PRPO · Real-Time Price · USD
20.66
-0.34 (-1.64%)
Oct 29, 2025, 4:00 PM EDT - Market closed
Precipio Market Cap
Precipio has a market cap or net worth of $33.45 million as of October 29, 2025. Its market cap has increased by 241.35% in one year.
Market Cap
33.45M
Enterprise Value
34.93M
1-Year Change
241.35%
Ranking
Category
Stock Price
$20.66
Market Cap Chart
Since July 18, 2000, Precipio's market cap has decreased from $510.60M to $33.45M, a decrease of -93.45%. That is a compound annual growth rate of -10.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 34.00M | 314.63% |
| Dec 31, 2024 | 8.20M | -10.87% |
| Dec 29, 2023 | 9.20M | -26.98% |
| Dec 30, 2022 | 12.60M | -64.90% |
| Dec 31, 2021 | 35.90M | 0.56% |
| Dec 31, 2020 | 35.70M | 134.87% |
| Dec 31, 2019 | 15.20M | 223.40% |
| Dec 31, 2018 | 4.70M | -60.83% |
| Dec 29, 2017 | 12.00M | 71.43% |
| Dec 30, 2016 | 7.00M | -53.02% |
| Dec 31, 2015 | 14.90M | -8.02% |
| Dec 31, 2014 | 16.20M | -60.10% |
| Dec 31, 2013 | 40.60M | -7.09% |
| Dec 31, 2012 | 43.70M | -31.40% |
| Dec 30, 2011 | 63.70M | 96.00% |
| Dec 31, 2010 | 32.50M | -4.13% |
| Dec 31, 2009 | 33.90M | 56.94% |
| Dec 31, 2008 | 21.60M | -18.49% |
| Dec 31, 2007 | 26.50M | 19.91% |
| Dec 29, 2006 | 22.10M | -57.58% |
| Dec 30, 2005 | 52.10M | 55.99% |
| Dec 31, 2004 | 33.40M | -34.89% |
| Dec 31, 2003 | 51.30M | -2.29% |
| Dec 31, 2002 | 52.50M | -79.44% |
| Dec 31, 2001 | 255.40M | 13.76% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.23B |
| Johnson & Johnson | 449.42B |
| AbbVie | 401.96B |
| UnitedHealth Group | 333.14B |
| AstraZeneca | 255.54B |
| Novartis AG | 239.27B |
| Novo Nordisk | 229.86B |
| Abbott Laboratories | 220.36B |